A PROSPECTIVE, OPEN-LABEL, NON-COMPARATIVE STUDY OF PALIVIZUMAB PROPHYLAXIS IN CHILDREN AT HIGH RISK OF SERIOUS RESPIRATORY SYNCYTIAL VIRUS DISEASE IN THE RUSSIAN FEDERATION Article Turti T.V., Baibarina E.N., Degtiareva E.A., Keshishyan E.S., Lobzin Y.V., Namazova-Baranova L.S., Prodeus A.P., Gudkov K.M., Kruglova A.I., Schulz G.A., Notario G.F. BMC Research Notes. Vol. 5. 2012.
FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION Article Баранов А.А., Baranov A.A., Намазова-Баранова Л.С., Namazova-Baranova L.S., Куличенко Т.В., Kulichenko T.V., Бакрадзе М.Д., Bakradze M.D., Дегтярева Е.А., Degtiareva E.A., Огородова Л.М., Ogorodova L.M., Гудков К.М., Gudkov K.M., Таточенко В.К., Tatochenko V.K., Gooch K.L., Notario G., Khong H., Buesch K. Педиатрическая фармакология. Vol. 8. 2011. P. 61-66
